Tumor cells circulating in blood are markers for the early detection and prognosis of cancer.
However, detection of these cells is challenging because of their scarcity. In the journal Angewandte Chemie, scientists have now introduced an ultrasensitive method for the direct detection of circulating tumor cells in blood samples. It is based on the amplified, time-resolved fluorescence measurement of luminescent lanthanide ions released from nanoparticles that bind specifically to tumor cells.
Conventional techniques for the detection of circulating tumor cells require complicated enrichment before detection because a sample of 10 million blood cells only contains about one tumor cell. In contrast, the new method developed by a team working with Xiaorong Song, Xueyuan Chen, and Zhuo Chen, at Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fujian Agriculture and Forestry University, and Fujian Cancer Hospital (Fuzhou, Fujian, China), works with no enrichment step and directly detects circulating tumor cells in blood samples. The technique is based on a so-called “dissolution-enhanced time-resolved photoluminescence” and uses fluorescing nanoparticles made of lanthanide europium complex.
First the researchers produced antibodies against the epithelial cell adhesion molecule (EpCAM, which is a glycoprotein that is present in very high numbers on the surfaces of many tumor cells and acts as a diagnostic marker for cancer). These antibodies were applied as a coating in the wells of microplates, causing tumor cells contained in the blood sample to remain stuck deep in the wells as other blood components were removed.
The scientists coated the europium-containing nanoparticles with the same antibodies. This caused large numbers of the nanoparticles, added in solution, to specifically bind to the tumor cells. A subsequently added “developer” dissolved the nanoparticles, releasing myriad europium ions. These were immediately bound and tightly locked up by other components of the developer solution. This resulted in a manifold amplification of the fluorescence.
Another essential advantage of this method is that europium ions are very long-lived fluorophores that continue to fluoresce for several microseconds after excitation with a flash of light. Because the measurements are time-resolved, it is possible to start the measurement with a delay. Background signals caused by the autofluorescence of cell components only continue for a few nanoseconds and fade before the measurement begins. This increases the sensitivity of the measurements, making it possible for the researchers to detect a single tumor cell per microplate well.
Tests with blood samples from cancer patients registered as few as 10 cells per milliliter of blood. Fourteen out of fifteen cancer patients were correctly identified by this new method. The number of tumor cells in the samples correlated strongly with the stage of cancer in each patient.
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Blood test that could detect 50 types of cancer getting massive trial in U.K.on November 27, 2020 at 3:26 pm
A California company says its blood test can discover 50 types of cancer in early stages, and the U.K. will put that claim to the test. Grail, a startup health company backed by Bill Gates and Jeff ...
- UK health service to pilot blood test that may detect 50 types of canceron November 27, 2020 at 11:26 am
The UK's National Health Service (NHS) is to pilot a simple blood test that may detect more than 50 types of cancer and, it is hoped, could help thousands of people by allowing the disease to be ...
- NHS to pilot ‘game-changer’ blood test that detects 50 types of cancer before people get sickon November 27, 2020 at 11:08 am
A blood test that may be able to spot more than 50 types of cancer will be piloted by the NHS, chief executive Sir Simon Stevens has announced. The Galleri blood test, which can detect early stage ...
- Blood Test That Detects 50 Types of Cancer To Be Testedon November 27, 2020 at 5:32 am
Researchers hope the Galleri blood test will be a "gamechanger" for early cancer diagnosis, potentially saving many lives.
- Covid is masking the symptoms of deadliest cancer in UK – the 10 signs you must never ignoreon November 27, 2020 at 5:10 am
COVID-19 is masking the symptoms of the deadliest cancer in UK, experts say. Lung cancer, which kills more than 35,300 Brits a year, has very similar characteristics to the coronavirus. The most ...
- 'Molecular clock' blood test could track spread of breast canceron November 27, 2020 at 3:58 am
A blood test to watch breast cancer's 'molecular clock' could help track the growth of multiple tumours around the body and monitor how they are responding to treatment, new research suggests.
- ‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast canceron November 26, 2020 at 9:39 pm
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.
- NHS to trial blood test to detect more than 50 forms of canceron November 26, 2020 at 8:37 pm
Researchers hopes Galleri trial will be a ‘gamechanger’ for early diagnosis and save many lives ...
- GRAIL and UK Government to Make Galleri Multi-Cancer Early Detection Blood Test Available to Patientson November 26, 2020 at 7:48 pm
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a partnership with the United Kingdom’s (UK) National Health Service (NHS) to help ...
- NHS to pilot blood test that could detect early signs of more than 50 types of canceron November 26, 2020 at 7:20 pm
A new blood test that could help detect the early signs of more than 50 types of cancer is set to be piloted across England by the NHS.
via Bing News